Indeed, selecting TF-Ag expressing PC-3 prostate cancer cells yielded a subpopulation of cells with enhanced stem cell properties such as clonogenic survival, clonogenic growth, prostasphere formation under both non-differentiating and differentiating conditions, and enhanced expression of stem cell markers compared with their TF-Ag negative counterparts. This evidence concerns the gene RENBP and prostate carcinoma.